Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity
Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity Written by: prnewswire.comOriginal Article NEW YORK, Jan. 12, 2023 /PRNewswire/ — Versanis Bio (“Versanis”), a clinical-stage biopharmaceutical company advancing novel …